GH1 and neoplasm: GH-transgenic mice (GH-Tg) have elevated levels of circulating GH and IGF-I, increased body size, experience premature and/or accelerated aging, higher tumor frequency, and have a ~50% reduced mean lifespan (Bartke, 2003).